Back to Search
Start Over
Development of Mass Spectrometry Imaging on skeletal muscle to characterize the local pro-inflammatory and pro-resolution lipid responses in a vaccination context.
- Source :
-
Journal of proteomics [J Proteomics] 2024 Mar 30; Vol. 296, pp. 105105. Date of Electronic Publication: 2024 Feb 05. - Publication Year :
- 2024
-
Abstract
- Vaccine reactogenicity is well documented at the clinical level but the mechanism involved at the local or systemic level are still poorly understood. Muscular tissue where most vaccines are administered is the first place of interaction between the vaccine formulation and the host's immune cells. So far, this site of vaccine administration is not well documented from a mechanistic standpoint. The study of early molecular events at the injection site is crucial to understand the local response to vaccines. In this paper, we report a standardized workflow, from the injection of vaccine formulations in rabbit muscle, to the analysis by desorption electrospray ionization and histology staining to understand the role of lipids involved in the inflammation and its resolution on striated muscular tissue. The analysis of lipid mediators was optimized at the site of needle insertion to allow the spatial comparison of cellular infiltrates at the injection site. We showed that lipids were distributed across the spatial tissue morphology in a time-dependent manner. The MS imaging applied to vaccinology could pave the way to a better understanding of vaccine reactogenicity and mechanism of action.<br />Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Emilie Chautard reports a relationship with Sanofi that includes: equity or stocks. Sebastien Laurent reports a relationship with Sanofi-Aventis Research and Development Montpellier that includes: equity or stocks. Patrick Syntin reports a relationship with Sanofi that includes: equity or stocks. Fabienne Piras-Douce reports a relationship with Sanofi that includes: equity or stocks. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper<br /> (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1876-7737
- Volume :
- 296
- Database :
- MEDLINE
- Journal :
- Journal of proteomics
- Publication Type :
- Academic Journal
- Accession number :
- 38325731
- Full Text :
- https://doi.org/10.1016/j.jprot.2024.105105